Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00046
http://purl.obolibrary.org/obo/dinto_DB00046
|
|---|---|
| Preferred Name | insulin lispro |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | insulin lispro
|
|---|---|
| label | insulin lispro
|
| DBSynonym | insulin lispro recombinant
|
| ATCCode |
A10AC04
A10AB04
A10AD04
|
| Definition | Insulin lispro is a recombinant human insulin analogue produced in a specialized laboratory strain of Escherischia coli. Plasmid DNA transfected into the bacteria encodes for an analogue of human insulin that has a lysine at residuce B28 and proline at B29; these residues are reversed in endogenous human insulin. Reversal of these amino acid residues produces a rapid-acting insulin analogue. FDA approved on 1996.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| induces | |
| activates | |
| type | |
| AHFScode | 68:20.08
|
| xref |
Drugs.com:http://www.drugs.com/mtm/insulin-lispro.html
RxList:http://www.rxlist.com/cgi/generic/insulinlispro.htm
PharmGKB:PA164747059
National Drug Code Directory:0002-7510-01
Drugs Product Database (DPD):2241283
Wikipedia:http://en.wikipedia.org/wiki/Insulin_lispro
See more
See less
|
| CASRN | 133107-64-9
|
| prefixIRI | obo2:dinto_DB00046
|
| related with | |
| may interact with |
See more
See less
|
| DBBrand |
humalog pen
humalog kwikpen
humalog
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |